Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067625
Filing Date
2017-11-13
Accepted
2017-11-13 06:53:09
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20657_110q.htm 10-Q 800404
2 EX-31.1 a17-20657_1ex31d1.htm EX-31.1 10219
3 EX-31.2 a17-20657_1ex31d2.htm EX-31.2 10177
4 EX-32.1 a17-20657_1ex32d1.htm EX-32.1 12224
  Complete submission text file 0001104659-17-067625.txt   3709552

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20170930.xml EX-101.INS 582147
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20170930.xsd EX-101.SCH 41637
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20170930_cal.xml EX-101.CAL 29010
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20170930_def.xml EX-101.DEF 162614
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20170930_lab.xml EX-101.LAB 379411
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20170930_pre.xml EX-101.PRE 281107
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 171192971
SIC: 2834 Pharmaceutical Preparations